According to the World Health Organization, Cancer is the second leading cause of death globally. Moreover, the WHO projects the number of global cancer deaths to increase by 45% between 2008 and 2030.
In respond to these rising numbers, the numbers of anti-cancer treatments will rise as well. Facing this global cancer burden, B. Braun supports the healthcare workforce worldwide to enable safe treatment of current and future patients. Oncology is a field of medical specialization using the full range of armamentarium of therapeutic approaches including nuclear therapy, surgery, radiation, etc. Infusion of anti-cancer drugs remains a mainstay of the therapy, whereby most of the drugs applied are exerting their effects as cytostatics or cytotoxics. As anti-cancer treatment is a highly specialized and diversified field of therapies and brings along a range of inherent risks both for patients as well as for healthcare workers, all process steps require special attention, care, knowledge and appropriately safe products.